Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 73 out of 100. How common it is

Topic: Risk, prevention and care in population studies

Plain-language summary

Objective To summarise available evidence on time to nursing home admission and death among people with dementia, and to explore prognostic indicators. Design Systematic review and meta-analysis. Data sources Medline, Embase, Web of Science, Cochrane, and Google Scholar from inception to 4 July 2024. Eligibility criteria for selecting studies Longitudinal studies on survival or nursing home admission in people with dementia. Studies with fewer than 150 participants, recruitment during acute hospital admission, or less than one year of follow-up were excluded. Results 19 307 articles were identified and 261 eligible studies included. 235 reported on survival among 5 553 960 participants and 79 reported on nursing home admission among 352 990 participants. Median survival from diagnosis appeared to be strongly dependent on age, ranging from 8.9 years at mean age 60 for women to 2.2 years at mean age 85 for men. Women overall had shorter survival than men (mean difference 4.1 years (95% confidence interval 2.1 to 6.1)), which was attributable to later age at diagnosis in women. Median survival was 1.2 to 1.4 years longer in Asia than in the US and Europe, and 1.4 years longer for Alzheimer's disease compared with other types of dementia. Compared with studies before 2000, survival was longer in contemporary clinic based studies (P trend =0.02), but not in community based studies. Taken together, variation in reported clinical characteristics and study methodology explained 51% of heterogeneity in survival. Median time to nursing home admission was 3.3 years (interquartile range 1.9 to 4.0). 13% of people were admitted in the first year after diagnosis, increasing to 57% at five years, but few studies appropriately accounted for competing mortality risk when assessing admission rates. Conclusions The average life expectancy of people with dementia at time of diagnosis ranged from 5.7 years at age 65 to 2.2 at age 85 in men and from 8.0 to 4.5, respectively, in women. About one third of remaining life expectancy was lived in nursing homes, with more than half of people moving to a nursing home within five years after a dementia diagnosis. Prognosis after a dementia diagnosis is highly dependent on personal and clinical characteristics, offering potential for individualised prognostic information and care planning. Systematic review registration PROSPERO CRD42022341507.

What this study adds

Evidence grade: High

This is a pooled review of 5,553,960 participants. This review of 261 studies describes how long people with dementia survive and when they enter nursing homes, with survival strongly depending on age at diagnosis. Its stated limit: Substantial heterogeneity (about half explained by study characteristics); few studies accounted for competing mortality risk when estimating admission; averages mask wide individual variation.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Brück, C. C., Mooldijk, S. S., Kuiper, L. M., Sambou, M. L., Licher, S., Mattace-Raso, F., et al. (2025). Time to nursing home admission and death in people with dementia: systematic review and meta-analysis. BMJ. https://doi.org/10.1136/bmj-2024-080636

Vancouver

Brück CC, Mooldijk SS, Kuiper LM, Sambou ML, Licher S, Mattace-Raso F, et al. Time to nursing home admission and death in people with dementia: systematic review and meta-analysis. BMJ. 2025. doi:10.1136/bmj-2024-080636. PMID: 39778977.

BibTeX

@article{bruck2025-39778977,
  author  = {Brück, C. C. and Mooldijk, S. S. and Kuiper, L. M. and Sambou, M. L. and Licher, S. and Mattace-Raso, F. and Wolters, F. J.},
  title   = {{Time to nursing home admission and death in people with dementia: systematic review and meta-analysis}},
  journal = {BMJ},
  year    = {2025},
  doi     = {10.1136/bmj-2024-080636},
  pmid    = {39778977},
  url     = {https://doi.org/10.1136/bmj-2024-080636}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This review of 261 studies describes how long people with dementia survive and when they enter nursing homes, with survival strongly depending on age at diagnosis. It provides prognostic information but does not test any treatment, cure, or prevention.

Study details

Limitations

Substantial heterogeneity (about half explained by study characteristics); few studies accounted for competing mortality risk when estimating admission; averages mask wide individual variation.

How this study scored 73/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 3 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 3 of 7; Citations per year 3 of 5; Impact for its field and year 4 of 6; Cited by studies here 2 of 6; Still being cited 2 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 72 of the 98 points it could be judged on, which is 73 of 100. Total 73 of 100.72 of the 98 points we could judge = 73 of 100

Published in a leading specialty journal, and it is a meta-analysis pooling many studies. We have no data on free to read, so that was left out: it earned 72 of the 98 points we could judge it on, which is 73 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (BMJ)
Journal's citation record 3 / 4 BMJ: journal h-index 413 (OpenAlex, 2026-10-29)
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 5,553,960 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited 3 / 7 Cited 34 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 11.3 citations a year over 3 year(s) since 2025
Impact for its field and year 4 / 6 Cited 8.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 2 / 6 Cited by 4 other studies in this library
Still being cited 2 / 4 Cited 34 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Frank J. Wolters: h-index 46 (OpenAlex, whole career)
Institution's track record 1 / 3 Erasmus MC: institution h-index 1,321 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 39778977)
Free to read — / 2 Access not recorded — left out of this score
Points 72 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 72 of the 98 points we could judge it on is 73 out of 100.
Total 73 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

4 studies in the alzhub library list this one in their references.

Related studies in How common it is from nearby years

Also tagged “nursing”

995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on How common it is

See all studies in How common it is →